Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Holding up today. Been moving nicely the last few days. Breakout Possible.
70+ page DD pack!! Wow.
https://docs.google.com/document/d/1_keOKay53ZgsB9DoUheBwXzJfS_IX9u5MdZWLxFIKkA/edit?usp=sharing
interview with the cannabis entrepreneur of all time!
Person of the year: @stevedeangelo Watch our interview with the cannabis entrepreneur of all time!https://t.co/fNF0Plo95B@CWjournals $CHNC #chncstock #cannabisindustry #mmj #Harborside #stevedeangelo
— CBIH (@CBIHstock) December 30, 2021
Where’s the name Change so sorry China infrastructure suck long time
Wang Dang Chang.. Triple zippies for this dumper it looks like. It's been so long since I followed this one I have forgotten what they are peddling.. Pot ? Chicken Chow Mein? Covid Cures?
in my opinion they are the preparations for a big climb that comes in December, and before a big climb there is a big drop
What the heck is going on with the OTC Market right now?
CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm
9:30 AM ET 11/17/21 | GlobeNewswire
CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm
HOUSTON, TX, Nov. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- China Infrastructure Construction Corp (OTC:CHNC): With no intention of litigating the past, we have cut ties with our previous PCAOB accounting firm with a full 1000% refund of all payments that were ever made to this company during our business relationship. In consequence, we have brought on a new Houston-based firm with an excellent reputation who promises to deliver the timely results our investors and we as a company expect.
With all things being equal, Vine Advisors/PWR CPA is determined to get us back on track. Whereby, we probably will receive our first ever PCAOB audited financials/accounting within the next 30 to 45 days.
"With our audit finalized, we have every intention to immediately submit our registration and name change hopefully before the end of 2021; we are looking forward to starting the first quarter of 2022 with a strong standing," states Henry Levinski, CHNC's Treasurer. With these processes completed, CHNC is ready to begin a new chapter in the company's history in which its audited financial reports, products and services will be aligned with a company whose reputation is beyond reproach.
CHNC will try to continue to deliver on its promises, in which we stand behind two main principles: Creating quality products that respond to the needs of the market while operating under full transparency as a company.
In addition, as our company is driven by commitment, dedication and progress, our team works in synergy and the advances are spread evenly across our different divisions. With this, CHNC is also pleased to announce that our advertising campaign process is smooth sailing; our colleagues are expediting the upload of our digital content and products to the 32 platforms with which we have contracts/agreements, which are the world's best positioned platforms in almost every continent.
For example, in Brazil we are uploading our content to Sympla, the country's biggest platform for virtual events and educational courses; in Spain we've developed a relationship with Aprendum, a virtual educational platform with over 50.000 students, and Alugha, a German company that will allow us to reach new markets such as the Asian continent, Russia, and Europe. In Latin America, Teachlr, which has over 200.000 Spanish-speaking users; in the Middle East, Unihance, the biggest decentralized e-learning platform; and in the United States as well as Mexico and Canada, we are working with Amazon, Walmart and Barnes and Noble, the world's leading eBook and audiobook marketplaces. More to the point, we are presently working on a relationship with Alibaba to be able to provide medical cannabis education in their Alibaba Educational Academy, for a total domination to the Asian markets.
As we slowly reach every corner in the world and conquer the global cannabis education market with a sustainable competitive advantage through the exposure to over 1 billion potential customers on a daily basis; we are also improving every aspect of our development process to match the exceptional quality of our products in order to dominate the market.
This coming year will be filled with expected additional revenue-generating centers designed to provide projected exposure and a booming financial growth to our company and our brand will continue to gain the lion's share of the market. We are building a strong foundation for our shareholders to thrive upon while improving our internal processes and developing new content at an increasing pace that will provide the building blocks for an exceptional 2022 in an industry with a market value expected to reach $75 billion by 2025.
To learn more visit: https://www.chnc-hdh.com/
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
> Dow Jones Newswires
November 17, 2021 09:30 ET (14:30 GMT)
the time is coming for CHNC , the sleeping giant is already awake
Works for me! They can quietly make us money.
this will go up without making noise, it is still in the buying area
This board has quieted down a lot! What's up, $CHNC bag-holders? Did we get hosed or is this turd going to move?
$CHNC CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador
Press Release | 11/05/2021
HOUSTON, TX, Nov. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- In CHNC’s continuing quest to broaden its horizons while spreading education about medicinal cannabis, a new collaboration has been forged with well renowned Drs. Nada AL-Rubaiee.
CHNC is honored to work along with someone with such an impressive curriculum. With a Bachelor’s degree from Leiden University (The Netherlands) in Bio-pharmaceutical sciences, a Masters in Pharmacy from the same school and a degree as Doctor of Health Administration from Walden University (USA), her academic achievements can only be matched by her professional background. During her career, she has served as Managing Director of Nadafarm Healthcare, in addition, she is currently the owner and director of Lyndensteyn B.V. consultancy services in which she has developed great leadership and team management skills which contributed to her achievement as Ethnic Business Women of the Netherlands.
As CHNC’s new brand ambassador, Drs. Nada would act as an extension of Pharmacology University to pursue our goal of creating more international alliances with academic institutions. Undoubtedly, this is a growing industry worldwide and countries who have been traditionally against legalization, such as Lebanon, are now viewing it as an opportunity to aid their economy. According to Lebanon's minister of economy, medicinal cannabis exports could generate $1 billion in annual revenue for the country.
They are not alone in this prediction, as other countries in the region can expect a net income from growing this plant for medicinal purposes of over $11,000 US dollars per hectare per year. Both Drs. Nada and CHNC agree that educational platforms play a key role in the industry as many of the stereotypes that have been created are a result of lack of information. Therefore, in this region it will be crucial to access education to make way for this blooming industry.
“We understand the complexities this industry entails, and the need to join forces with allies who have the same level of commitment with education as CHNC has. We could not have wished for a better representative than Drs. Nada. Her work and tenacity in the industry continues to inspire us to develop new educational options for the public,” says Jennifer Simbaña - CHNC’s Developer of International Markets.
This is another brick that paves the road to a financially successful 2022 while coming closer to our ultimate goal: being the international leader in education in the medical cannabis industry, in a market that promises to have global legal sales by 2026 of USD $90.4 billion (Business Wire).
To learn more visit: https://www.chnc-hdh.com/
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
alright, alright, alright... Just jumped on this boat today... lets see where we go from here. I like what I'm seeing.
CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador
Press Release | 11/05/2021
$CHNC CHNC Announces a New Member of Its Board of Directors
Press Release | 10/20/2021
HOUSTON, TX, Oct. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) announces that Elizabeth Hernandez, a member of its board of directors and its Chief Operating Officer, has left the Company (July 28th, 2021) and is no longer serving in these capacities. The Company is not aware of her future plans.
Nevertheless, this position will not remain empty and has been filled with one of the team’s responsible architects of International Strategic Alliances. “We are pleased to announce that we will be welcoming one of our very best as a member of our Board of Directors, Anne Marie Graham, Attorney at Law and CHNC’s Director of International Markets,” says Henry Levinski, CHNC’s Treasurer.
Since her arrival at CHNC she has contributed to the Company her years of business acumen, as well as her experience as a corporate lawyer, developing partnerships with international academic institutions.
Previous to her new responsibilities, she was in charge of the well-known Cannabis World Journals magazine. Ms. Graham was instrumental in achieving successful alliances with ICESI University in Cali, as well as the negotiations with a variety of Latin American academic institutions to expand the reach of CHNC all over the world. As a result, she received the title of CLO.
As an attorney at law, she has made sure the company is at the top of the game in legal developments within the industry and has kept our audiences informed of the regulatory frameworks that are sometimes so hard to manage within this industry. Her vast background in public speaking, as attested with her numerous victories in contests such as the III Iberoamerican Tax Moot Court held by the University of Florida in Gainesville, made her a keen mediator in every new deal we have struck, and her legal background has given us the advantage in each contract we have drafted. The lion’s share of our growth as a company is due to her excellent management skills which turned our expanding ranks into a well-oiled machine.
“As one of the Directors of the company I have witnessed production and execution and now I am eager to fulfill my duties as a Member of the Board moving CHNC forward to higher profitability while continuing to expand our grasp in new and exciting markets,” states Anne Marie Graham.
We wish her the very best in this new professional turn in her career and having had the pleasure to work alongside her, we now are excited to see the great new lengths this company will reach with the help of her guidance in her new responsibilities.
To learn more visit: https://www.chnc-hdh.com/
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
Duly noted !!
CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content
Press Release | 10/18/2021
HOUSTON, TX, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Through artificial intelligence technology and various platform alliances around the globe, in approximately 30 to 45 days China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) will be able to distribute our educational products in the following additional languages: Mandarin, Cornish, Czech, Dutch, French, German, Greek, Hebrew, Hindi, Japanese, Kazakh, Korean, Polish, Russian, Tagalog, and Vietnamese.
Entering newer and emerging markets such as Russia, China or Japan is a landmark in our journey and a milestone in our industry. All of this will be possible with the implementation of artificial intelligence to our arsenal, allowing us to explore new ways of reaching a broader global audience. “It will grant us the opportunity to develop our content alongside subtitles and audios in other languages the same way Netflix seamlessly does. The sky is the limit in what we can achieve with artificial intelligence,” says Anne Graham, Attorney at Law, CHNC’s Director of International Markets.
Furthermore, with this innovative technology, our content will break down the language barriers in many regions and will now have access to potential paying customers in 150 countries.
Moreover, with the new added platforms that will join the list of our worldwide alliances such as Unihance in Jordan, Alugha in Germany, Pocketmagazines, Zinio, Smashwords, Findawayvoices and Publishdrive, CHNC will now have exposure to over 500 million potential customers around the world. Therefore, uploading the content to each and every one of these platforms is a process that has and will keep us busy for the next couple of months. We expect that by December 2021 all of our educational materials will be properly uploaded. Hence, CHNC hopes to bring in additional revenues for 2022 to the tune of $1 million to $1.5 million. We believe that with this level of exposure, combined with the quality of our content and hard work, this strategy will represent a 180 degree turn for the financial journey of CHNC.
We are also glad to announce that it is not only our line of products that is expanding but our ever-growing line of excellent personnel. We have welcomed 6 new associates during this last week and will be looking forward to retaining the services of 6 to 10 more hopefully by the end of the month. The acquisition of extra partners will enable us to meet our ambitious growth demands and will pave the way for the end of the year goals of launching our sales campaign during the holiday season in order to gain a strong entrance for 2022.
“As our company continues to grow, CHNC has to expand in order to reach new markets, regions and communities, and to match the level of innovation, production and execution that our team delivers day by day,” says Henry Levinski, CHNC’s Treasurer.
To learn more visit: https://www.chnc-hdh.com/
Looks great !
Look at the chart. Imo moving back above .005
One turd is as good as another, I guess.
Except $CHNC isn't quite at turd level yet.
Ha! Feet don’t fail me now..
$CHNC CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived Therapeutics
Press Release | 10/01/2021
HOUSTON, TX, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings), announced today that it is actively seeking strategic partners to invest up to $3 million in two or three tranches although there can be no assurance that any such investment can be obtained on acceptable terms, or at all. The company has been diligently working around the clock actively entertaining proposals from quality groups that will bring proprietary knowledge and expertise to support and accelerate its ongoing revenue streams and build new revenue-generating centers in the U.S. and internationally.
“Our first priority is to continue to solidify the foundation of our existing digital products and services such as our Cannabis World Journals, eBooks, educational videos, sleep center and clinical studies,” said Henry Levinski, CHNC´s Treasurer. “We have set challenging goals in all of these areas and are determined to reach or exceed them; for example, we will continue to gain our proper share of the market by featuring our products in new languages such as Mandarin, French, German and Hindi.”
The company will continue to invest in its internal staff of associates, which has grown from approximately 20 to over 60 within the past year. “We are very proud of the team we have built, and we intend to continue to add value through our association of professionals all striving for our common goal of stability and growth,” said Anne Graham, CHNC’s Corporate Attorney and VP of Operations. “With this additional funding we have set a goal of building our staff to 250 by the third quarter of 2022.”
Furthermore, we will also use part of this funding to start research on the medical benefits of cannabis and the implication of cannabinoids on body homeostasis with a 18-months clinical trial on healthy individuals and patients with pathologies associated with endocannabinoid system disorders; this research aims to provide the scientific data required to establish cannabis as a safe and effective alternative in various diseases.
More importantly, we will move to establish a manufacturing facility for a number of medical, nutraceutical, and vitamin supplement products utilizing therapeutic derivatives of cannabis to assist patients suffering from diseases such as cancer, multiple sclerosis, epilepsy and many more. We are committed to working within U.S. and international laws and will only develop and distribute our products and services accordingly.
Certainly, one of the characteristics of CHNC is innovation and we are convinced that investment focused on these areas will allow us to grow and continue to yield the investment-returns (ROI) experienced so far by our investors and much more. To learn more visit: https://www.chnc-hdh.com/
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived TherapeuticsPress Release | 10/01/2021
HOUSTON, TX, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings), announced today that it is actively seeking strategic partners to invest up to $3 million in two or three tranches although there can be no assurance that any such investment can be obtained on acceptable terms, or at all. The company has been diligently working around the clock actively entertaining proposals from quality groups that will bring proprietary knowledge and expertise to support and accelerate its ongoing revenue streams and build new revenue-generating centers in the U.S. and internationally.
“Our first priority is to continue to solidify the foundation of our existing digital products and services such as our Cannabis World Journals, eBooks, educational videos, sleep center and clinical studies,” said Henry Levinski, CHNC´s Treasurer. “We have set challenging goals in all of these areas and are determined to reach or exceed them; for example, we will continue to gain our proper share of the market by featuring our products in new languages such as Mandarin, French, German and Hindi.”
The company will continue to invest in its internal staff of associates, which has grown from approximately 20 to over 60 within the past year. “We are very proud of the team we have built, and we intend to continue to add value through our association of professionals all striving for our common goal of stability and growth,” said Anne Graham, CHNC’s Corporate Attorney and VP of Operations. “With this additional funding we have set a goal of building our staff to 250 by the third quarter of 2022.”
Furthermore, we will also use part of this funding to start research on the medical benefits of cannabis and the implication of cannabinoids on body homeostasis with a 18-months clinical trial on healthy individuals and patients with pathologies associated with endocannabinoid system disorders; this research aims to provide the scientific data required to establish cannabis as a safe and effective alternative in various diseases.
More importantly, we will move to establish a manufacturing facility for a number of medical, nutraceutical, and vitamin supplement products utilizing therapeutic derivatives of cannabis to assist patients suffering from diseases such as cancer, multiple sclerosis, epilepsy and many more. We are committed to working within U.S. and international laws and will only develop and distribute our products and services accordingly.
Certainly, one of the characteristics of CHNC is innovation and we are convinced that investment focused on these areas will allow us to grow and continue to yield the investment-returns (ROI) experienced so far by our investors and much more. To learn more visit: https://www.chnc-hdh.com/
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
Primary Logo
https://www.otcmarkets.com/stock/CHNC/news/CHNC-to-Seek-Up-to-3-Million-Funding-for-Expansion-of-Existing-Product-Lines-and-Development-of-New-Cannabis-Derived-The?id=323334
Doesn’t matter to me. I’m out. I bought a sh*t load of SHMN today instead
Their PRs are written by morons. Complete and total morons.
They don't do themselves any favors with certain PRs lol, but imo this seems like it might be bottoming out and approaching a decent reloading zone all things considered, and comparing it to the post-compliance pink current landscape.
He seems to stupid….Or too stoned…..to think of that
Yep! But he could throw a lifeline when he sees this tanking 50% from last week...it is the otc...fibonacci retraced pro'lly to 0.0025
Yes..I am waiting at 0.0025 to 0.0026 for a 25% to 35% bounce...glta. 200dma support bounce!!!
Anybody that reads the tweets of the idiot ceo wouldn’t touch this with a ten foot pole. GLTY
0.0025 support coming. glta..chnc is a risky investment
Yes. The company seems to have promising results though. I’m not co corner about a name change. Could need to test the .002’s but I would imagine that would be a significant loading zone for an east and quick 100%. Just my opinion.
New release and quote from June 14 2021:
"The Company believes that it will be able to complete this process during the next 3 months. "
He said it would take three months in June. Now another 3-4 months.
.002' around the corner.
Wow. I didn’t see that. No wonder it’s tanking
Didn’t they say they’re still a few months out and to be patient? He said best case 3-4 months if that’s what he’s referring to. So hopefully I’m the new year.
We are looking at a best case scenario of 3 or 4 months. Please help me be patient, I probably need to go on celexa or prozac, haha. Thank you for your patience and understanding.
— Dante Picazo (@dante_picazo) September 24, 2021
So where’s the news, ticker and name change that they keep saying is coming?
Followers
|
204
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
11787
|
Created
|
11/08/09
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |